Nomogram Based on Immune-Inflammatory Score and Classical Clinicopathological Parameters for Predicting the Recurrence of Endometrial Carcinoma: A Large, Multi-Center Retrospective Study
Open Access
- 1 December 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 11437-11449
Abstract
Background: Surgery is the best approach to treat endometrial cancer (EC); however, there is currently a deficiency in effective scoring systems for predicting EC recurrence post-surgical resection. This study aims to develop a clinicopathological-inflammatory parameters-based nomogram to accurately predict the postoperative recurrence-free survival (RFS) rate of EC patients. Methods: A training set containing 1068 patients and an independent validation set consisting of 537 patients were employed in this retrospective study. The prognostic factors for RFS were identified by univariable and multivariable Cox proportional hazards regression analyses, and integrated into nomogram. The C-index, area under the curves (AUC), and calibration curves were employed to determine the predictive discriminability and accuracy of nomogram. Utilizing the nomogram, patients were stratified into low- and high-risk groups, and the Kaplan-Meier survival curve was further employed to assess the clinical efficacy of the model. Results: Cox regression analyses revealed that age (HR = 1.769, P = 0.002), FIGO staging (HR = 1.790, P = 0.018), LVSI (HR = 1.654, P = 0.017), Ca125 (HR = 1.532, P = 0.023), myometrial invasion (HR = 1.865, P = 0.001), cervical stromal invasion (HR = 1.655, P = 0.033), histology (HR = 2.637, P < 0.001), p53 expression (HR = 1.706, P = 0.002), PLR (HR = 1.971, P = 0.003), SIRI (HR = 2.187, P = 0.003), and adjuvant treatment (HR = 0.521, P = 0.003) were independent prognostic factors for RFS in patients with EC. A combined clinicopathologic-inflammatory parameters model was constructed, which outperformed the single-indicator model and other established models in predicting the 1-, 3-, and 5-year RFS rates in patients with EC. Conclusion: The nomogram demonstrated sufficient accuracy in predicting the RFS probabilities of EC, enabling personalized clinical decision-making for future clinical endeavors.Keywords
This publication has 35 references indexed in Scilit:
- Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomesEuropean Journal of Surgical Oncology, 2024
- Incidence, risk factors, and a prognostic nomogram for distant metastasis in endometrial cancer: A SEER‐based studyInternational Journal of Gynecology & Obstetrics, 2023
- Optimization of patient-based real-time quality control based on the Youden indexClinica Chimica Acta, 2022
- Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapyCancer Communications, 2022
- TCGA molecular groups of endometrial cancer: Pooled data about prognosisGynecologic Oncology, 2019
- Endometrial Cancer: An Overview of Pathophysiology, Management, and CareSeminars in Oncology Nursing, 2019
- Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) CentersGynecologic Oncology, 2018
- Retrospective study of the prognostic significance of neutrophil‐to‐lymphocyte ratio for postsurgical outcomes of patients with endometrial carcinomaInternational Journal of Gynecology & Obstetrics, 2017
- Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial CancerJAMA, 2017
- Follow-up after primary therapy for endometrial cancer: A systematic reviewGynecologic Oncology, 2006